|
Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of drugs in the areas of infectious disease, oncology and respiratory disease. The Company has assembled a pipeline of clinical and preclinical product candidates. The Company has a worldwide license (excluding Japan) from Abbott Laboratories (Abbott) to develop and commercialize cethromycin (Restanza), once-a-day antibiotic for the treatment of respiratory tract infections. Along with its clinical work in the treatment of community acquired bacterial pneumonia (CABP), the Company is collaborating with several groups within the United States Government to evaluate cethromycin's potential in preventing inhalation anthrax and other high-priority bioterror agents. |